Novo Nordisk cuts profit forecast amid US challenges
Shares in the world's largest maker of diabetes treatments, Novo Nordisk, fell by more than 19 percent on Friday after it cut its profit forecast, reflecting tough competition in the US market.
Oct 28, 2016
0
0